Metamizol Auxpharma

Metamizole, the active ingredient in Metamizol Auxpharma, is a pyrazolone analgesic presented as an oral formulation for oral use. It is employed to relieve acute pain, reduce fever, and manage post‑operative discomfort and colic in adult patients.

GNH USA supplies Metamizol Auxpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metamizole is a non‑opioid analgesic and antipyretic that acts on pain‑related and febrile pathways.

Acute pain: provides rapid relief of severe short‑term pain such as injury or trauma. Fever: lowers elevated body temperature in infectious or inflammatory conditions. Post‑operative pain: helps control pain after surgical procedures. Colic: eases visceral pain associated with gastrointestinal spasm.

Metamizole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: occasional upset stomach. - Vomiting: occasional emesis. - Dizziness: transient light‑headedness. - Headache: mild to moderate. - Skin rash: mild erythema or itching. - Hypotension: transient low blood pressure.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells. - Severe allergic reactions: anaphylaxis or angioedema. - Blood dyscrasias: thrombocytopenia or hemolytic anemia. - Hepatic enzyme elevation: possible liver injury. - Stevens‑Johnson syndrome: severe skin reaction. - Anaphylactic shock: life‑threatening hypersensitivity.

Before prescribing Metamizole, clinicians should consider several safety measures.

Assess renal function: adjust use in patients with impaired kidneys. Monitor blood counts: periodic CBC to detect agranulocytosis. Avoid in known hypersensitivity: contraindicated for patients allergic to pyrazolones. Use caution in the elderly: increased risk of hypotension and renal effects. Avoid concomitant use with other NSAIDs: higher risk of gastrointestinal bleeding. Store at room temperature: keep in the original pack, protect from moisture.

Metamizole can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Myelosuppressive agents: combined use may exacerbate bone‑marrow suppression. - Sulfonamides: increased risk of severe blood dyscrasias. - Anticoagulants: may enhance bleeding tendency.

Moderate Interactions (Monitor Closely): - NSAIDs: additive gastrointestinal irritation. - Diuretics: potential for reduced renal perfusion. - ACE inhibitors: possible additive hypotensive effect.